Latest Stories
3 Stocks Under $10 We Keep Off Our Radar
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
3 Russell 2000 Stocks with Open Questions
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
3 of Wall Street’s Favorite Stocks to Keep an Eye On
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
2 Reasons to Sell SAIC and 1 Stock to Buy Instead
Shareholders of SAIC would probably like to forget the past six months even happened. The stock dropped 26.6% and now trades at $87.72. This may have investors wondering how to approach the situation.
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
3 Reasons to Sell FUBO and 1 Stock to Buy Instead
Shareholders of fuboTV would probably like to forget the past six months even happened. The stock dropped 65.9% and now trades at $1.18. This might have investors contemplating their next move.
2 Reasons to Like FRSH (and 1 Not So Much)
Shareholders of Freshworks would probably like to forget the past six months even happened. The stock dropped 45.6% and now trades at $7.17. This might have investors contemplating their next move.
3 Reasons to Avoid QTWO and 1 Stock to Buy Instead
Q2 Holdings’s stock price has taken a beating over the past six months, shedding 38.5% of its value and falling to $47.20 per share. This may have investors wondering how to approach the situation.
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Molina Healthcare’s shares (currently trading at $145.75) have posted a disappointing 16.6% loss, well below the S&P 500’s 6.5% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Avoid NEO and 1 Stock to Buy Instead
What a fantastic six months it’s been for NeoGenomics. Shares of the company have skyrocketed 48.3%, hitting $9.94. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.